Press Releases about Gilead Sciences
![](https://www.marketbeat.com/images/MarketBeat-icon-256x256.png)
![](https://www.marketbeat.com/logos/articles/med_20240621074929_gilead-sciences-stock-surges-on-hiv-treatment-tria.jpg)
![](https://mms.businesswire.com/media/20240620044585/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
![](https://ml.globenewswire.com/media/f326183f-8829-42af-8851-525b1d7503ed/small/finacialnews-logo-final-01-2-png.png)
![](https://mms.businesswire.com/media/20240614729632/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20240606954431/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240604334684/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240603095365/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20240603718191/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20240531380992/en/2147242/5/ARCUS_Logo_RGB_1920x1080.jpg)
![](https://mms.businesswire.com/media/20240531335673/en/2147237/5/ARCUS_Logo_RGB_1920x1080.jpg)
![](https://mms.businesswire.com/media/20240530725767/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240530516266/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Provides Update on Phase 3 TROPiCS-04 Study
May 30, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240522704668/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://dj5dehgem20mk.cloudfront.net/img/logo-2.png)
Via PRLog
![](https://mms.businesswire.com/media/20240518003116/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240514656201/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20240509189414/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20240506028033/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20240430344533/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Sciences to Present at Upcoming Investor Conferences
April 30, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240426676086/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240425746971/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20240408350262/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240401185946_biotech-sector-nears-breakout-will-it-outperform-i.jpg)
![](https://mms.businesswire.com/media/20240327502740/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240328734624/en/2082732/5/Xilio_Full_CLR_Logo_CMYK_%5Bwith_registered_mark%5D.jpg)
![](https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.